[Treatment of cardiogenic shock].
D000138:Acidosis / Q000188:drug therapy; D001639:Bicarbonates / Q000627:therapeutic use; D002301:Cardiac Glycosides / Q000627:therapeutic use; D002306:Cardiac Volume / Q000187:drug effects; D003331:Coronary Vessels; D003911:Dextrans / Q000627:therapeutic use; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D011955:Receptors, Drug; D012770:Shock, Cardiogenic / Q000188:drug therapy*; D013256:Steroids / Q000627:therapeutic use; D013565:Sympatholytics / Q000627:therapeutic use; D013566:Sympathomimetics / Q000627:therapeutic use; D014692:Ventilation-Perfusion Ratio
D001639:Bicarbonates; D002301:Cardiac Glycosides; D003911:Dextrans; D011955:Receptors, Drug; D013256:Steroids; D013565:Sympatholytics; D013566:Sympathomimetics; D006493:Heparin
Die Behandlung des kardiogenen Schocks.